| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18497959 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 102 journal articles in the PubMed database | Email to a friend | | |
| Hubeek I, Comijn EM, Van der Wilt CL, et al.
CI-994 (N-acetyl-dinaline) in combination with conventional anti-cancer agents is effective against acute myeloid leukemia in vitro and in vivo. [Journal Article]
Oncol Rep 2008 Jun; 19(6):1517-23.
Abstract | Full Citation | Find Related Articles | | Hagenbeek A, Weiershausen U, Martens AC
Dinaline: a new oral drug against leukemia? Preclinical studies in a relevant rat model for human acute myelocytic leukemia (BNML). [Journal Article]
Leukemia 1988 Apr; 2(4):226-30.
Abstract | Full Citation | Find Related Articles | | Büchner T, Hiddemann W, Wörmann B, et al.
Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Blood 1999 Jun 15; 93(12):4116-24.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hiddemann W, Kreutzmann H, Straif K, et al.
High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia. [Journal Article]
Semin Oncol 1987 Jun; 14(2 Suppl 1):73-7.
Abstract | Full Citation | Find Related Articles | | Löwenberg B, Suciu S, Archimbaud E, et al.
Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial]
J Clin Oncol 1998 Mar; 16(3):872-81.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hiddemann W, Kreutzmann H, Straif K, et al.
High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemia. [Journal Article]
Blood 1987 Mar; 69(3):744-9.
Abstract | Full Citation | Find Related Articles | | Creutzig U, Ritter J, Zimmermann M, et al.
Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93. [Clinical Trial, Journal Article, Randomized Controlled Trial]
J Clin Oncol 2001 May 15; 19(10):2705-13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Pavlovsky S, Gonzalez Llaven J, Garcia Martinez MA, et al.
A randomized study of mitoxantrone plus cytarabine versus daunomycin plus cytarabine in the treatment of previously untreated adult patients with acute nonlymphocytic leukemia. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Ann Hematol 1994 Jul; 69(1):11-5.
Abstract | Full Citation | Find Related Articles | | Koc Y, Oyan B, Kars A, et al.
A randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in newly diagnosed patients with acute myeloblastic leukemia. [Clinical Trial, Journal Article, Randomized Controlled Trial, Review]
Hematol Oncol 2004 Jun; 22(2):43-53.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
